Literature DB >> 24343604

Comparative pharmacokinetics studies of benzoylhypaconine, benzoylmesaconine, benzoylaconine and hypaconitine in rats by LC-MS method after administration of Radix Aconiti Lateralis Praeparata extract and Dahuang Fuzi Decoction.

Xiao Liu1, Huan Li, Xiaoqing Song, Kunming Qin, Hui Guo, Li Wu, Hao Cai, Baochang Cai.   

Abstract

A rapid and sensitive high-performance liquid chromatography-mass spectrometric (HPLC-MS) method was developed and validated for simultaneous determination of benzoylhypaconine (BHA), benzoylmesaconine (BMA), benzoylaconine (BAC) and hypaconitine (HA) in rat plasma for the first time. The analytes were separated on a Kromasil C₁₈ column with a total running time of 11 min. The validation data demonstrated a sound feasibility for the newly developed method and it was then applied to the pharmacokinetic study of these analytes in rats. Pharmacokinetic behaviors of BHA, BMA, BAC and HA in rats were studied after oral administration of Radix Aconiti Lateralis Praeparata extract (FZ) and Dahuang Fuzi Decoction (DFD). The main parameters for the two groups of subjects were compared, and significant differences between Radix Aconiti Lateralis Praeparata extract group and Dahuang Fuzi Decoction group in calculated parameters, such as the area under the plasma concentration-time from zero to the last quantifiable time-point (AUC(₀-t)), the area under the plasma concentration-time curve from zero to infinity (AUC(₀-∞)), peak plasma concentration (C(max)), half-life of elimination (T₁/₂), mean retention time (MRT(₀-t)), plasma clearance (CL), volume of distribution (V(d)) and time to reach Cmax (T(max)), were found. After oral administration of DFD, the AUC(₀-t), AUC(₀-∞) and C(max) of BHA, BMA, BAC and HA decreased remarkably (p < 0.05) compared with those of the FZ extract group. Vd and CL values of BHA, BMA, BAC and HA increased, two of which showed significant difference (p < 0.05). T₁/₂ and MRT(₀-t) values of BHA, BMA and BAC in the DFD group were significantly delayed compared with those of FZ extract group. Only the T(max) of HA, the toxic ingredient in FZ, delayed significantly in DFD group compared with the value of FZ group. All these pharmacokinetic parameters were statistically compared, and the rationality of the combination for DFD was clearly demonstrated.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS; benzoylaconine; benzoylhypaconine; benzoylmesaconine; hypaconitine; pharmacokinetic

Mesh:

Substances:

Year:  2013        PMID: 24343604     DOI: 10.1002/bmc.3102

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

1.  Metabolic Behaviors of Aconitum Alkaloids in Different Concentrations of Aconiti Lateralis Radix Praeparata and Effects of Aconitine in Healthy Human and Long QT Syndrome Cardiomyocytes.

Authors:  Liang Yang; Guanghui Xie; Yuguang Wang; Jian Li; Bin Zheng; Jinmiao Zhu; Xinsong Yuan; Qian Hong; Zengchun Ma; Yue Gao
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

2.  Compatibility of Fuzi and Ginseng Significantly Increase the Exposure of Aconitines.

Authors:  Ze-Yan Chen; Xu-Ya Wei; Zi-Dong Qiu; Yun Huang; Ting Tan; Yu-Lin Feng; Juan Guo; Guang-Hong Cui; Lu-Qi Huang; Chang-Jiang-Sheng Lai
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

3.  Ignavine: a novel allosteric modulator of the μ opioid receptor.

Authors:  Katsuya Ohbuchi; Chika Miyagi; Yasuyuki Suzuki; Yasuharu Mizuhara; Keita Mizuno; Yuji Omiya; Masahiro Yamamoto; Eiji Warabi; Yuka Sudo; Akinobu Yokoyama; Kanako Miyano; Takatsugu Hirokawa; Yasuhito Uezono
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

4.  Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats.

Authors:  Liqin Wang; Yu He; Yuyan Zhang; Huifen Zhou; Li Yu; Jiehong Yang; Haitong Wan
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-08       Impact factor: 2.629

5.  Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration.

Authors:  Yuqiao Zhang; Dali Tian; Yuyou Huang; Ling Li; Juan Mao; Juan Tian; Jinsong Ding
Journal:  Acta Pharm Sin B       Date:  2016-06-11       Impact factor: 11.413

6.  In Vivo Pharmacokinetic Analysis Utilizing Non-Targeted and Targeted Mass Spectrometry and In Vitro Assay against Transient Receptor Potential Channels of Maobushisaishinto and Its Constituent Asiasari Radix.

Authors:  Takashi Matsumoto; Mikina Takiyama; Shou Sanechika; Akiko Nakayama; Katsuyuki Aoki; Katsuya Ohbuchi; Hirotaka Kushida; Hitomi Kanno; Akinori Nishi; Junko Watanabe
Journal:  Molecules       Date:  2020-09-18       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.